ADBiotech Co., Ltd. (KOSDAQ:179530)
3,750.00
-230.00 (-5.78%)
At close: Aug 7, 2025, 3:30 PM KST
ADBiotech Revenue
ADBiotech had revenue of 3.45B KRW in the quarter ending March 31, 2025, with 17.88% growth. This brings the company's revenue in the last twelve months to 11.66B, up 12.56% year-over-year. In the year 2024, ADBiotech had annual revenue of 11.14B with 6.34% growth.
Revenue (ttm)
11.66B
Revenue Growth
+12.56%
P/S Ratio
4.05
Revenue / Employee
197.63M
Employees
59
Market Cap
47.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.14B | 664.30M | 6.34% |
Dec 31, 2023 | 10.47B | -159.63M | -1.50% |
Dec 31, 2022 | 10.63B | -1.21B | -10.21% |
Dec 31, 2021 | 11.84B | 2.02B | 20.63% |
Dec 31, 2020 | 9.82B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
HD Hyundai Heavy Industries | 15.32T |
Doosan Enerbility | 15.88T |